IGMPI India



Dr. Reddy recalls heartburn drug from US market

Dr. Reddy has issued a voluntary recall of Lansoprazole delayed release capsules, which is a generic version of Swiss drugmaker Novartis drug Prevacid. The US FDA said that the company recalled 58,656 bottles of its Lansoprazole formulation from US market due to microbial contamination.

Lansoprazole is a proton pump inhibitor (PPI) which inhibits the stomach’s production of gastric acid. It is widely used in treatment of ulcers of the stomach and duodenum and NSAID induced ulcers and also used in treatment of Helicocacter pylori infection.

The FDA classified the recall as a "Class II" recall which indicates a remote chance of severe adverse consequences or death due to the product flaw.